Evidence of improving quality of reporting of randomized controlled trials in subfertility

By Dias Sofia   McNamee Roseanne   Vail Andy  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2617-2627

Oxford University Press

Access to resources Recommend Favorite

The Reporting of Harms in Randomized Controlled Trials of Hypertension Using the CONSORT Criteria for Harm Reporting

By Bagul Nitin Babulal   Kirkham Jamie J.  

Clinical and Experimental Hypertension, Vol. 34, Iss. 8, 2012-12 ,pp. : 548-554

Informa Healthcare

Access to resources Recommend Favorite

Sample Size Justification in Phase III/IV Clinical Trials

By  

Neuroepidemiology, Vol. 17, Iss. 2, 1998-04 ,pp. : 63-66

Karger

Access to resources Recommend Favorite

Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 3, 2016-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Controlled Trial of β-Blockers Versus Endoscopic Band Ligation for Primary Prophylaxis: A Large Sample Size is Required to Show a Difference in Bleeding Rates

By Thuluvath Paul   Maheshwari Anurag   Jagannath Sanjay   Arepally Aravind  

Digestive Diseases and Sciences, Vol. 50, Iss. 2, 2005-02 ,pp. : 407-410

Springer Publishing Company

Access to resources Recommend Favorite